Learning & education: Non-alcoholic fatty liver disease

Cordycepin: A Promising Ally Against Metabolic Disorders
Mar 07, 2024
Cordycepin exhibits potent therapeutic activity against cancer, hyperlipidemia, and diabetes, and is also a strong immunomodulator. It also shows potential as a therapeutic agent for metabolic disorders such as diabetes or non-alcoholic fatty liver disease.

AI-generated responses are for informational purposes only and do not constitute medical advice. Accuracy, completeness, or timeliness are not guaranteed. Use at your own risk.

Trixie - AI assistant

close